Hospital management of hyperglycemia in the context of COVID-19: evidence-based clinical considerations

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.contributorUniversidade Estadual Paulista (UNESP)-
Autor(es): dc.contributorUniversidade de São Paulo (USP)-
Autor(es): dc.contributorHospital 9 de Julho-
Autor(es): dc.creatorMendes, Thiago Bosco-
Autor(es): dc.creatorCâmara-de-Souza, Alexandre Barbosa-
Autor(es): dc.creatorHalpern, Bruno-
Data de aceite: dc.date.accessioned2025-08-21T21:41:47Z-
Data de disponibilização: dc.date.available2025-08-21T21:41:47Z-
Data de envio: dc.date.issued2022-04-29-
Data de envio: dc.date.issued2022-04-29-
Data de envio: dc.date.issued2022-11-30-
Fonte completa do material: dc.identifierhttp://dx.doi.org/10.1186/s13098-022-00808-x-
Fonte completa do material: dc.identifierhttp://hdl.handle.net/11449/230558-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/11449/230558-
Descrição: dc.descriptionThe COVID-19 pandemic led to an unprecedented crisis, and early on, it has been shown that diabetes is an important risk factor for complications and mortality in infected patients, as demonstrated by several studies. Moreover, hyperglycemia, regardless of whether patients have diabetes, is associated with poorer outcomes, which suggests that adequate monitoring and treatment of elevated glycemia in the hospital setting can improve patient outcomes. In patients with COVID-19, glycemic control may be impaired as a consequence of the infection itself (aggravating pre-existing diabetes and potentially precipitating new-onset diabetes), inflammation, or corticosteroid use—a well-established therapy to reduce COVID-19 complications, especially in the intensive care unit. This article reviews the link between diabetes and hyperglycemia, and COVID-19, with a brief review of potential mechanisms, along with emerging evidence on the effect of glycemic control on COVID-19 outcomes, especially in hospital settings.-
Descrição: dc.descriptionDepartment of Internal Medicine Hospital das Clínicas São Paulo State University (UNESP)-
Descrição: dc.descriptionDepartment of Endocrinology Hospital das Clínicas University of São Paulo (USP)-
Descrição: dc.descriptionDepartment of Endocrinology Hospital 9 de Julho, Rua Alves Guimarães, 462, cj. 72, Pinheiros, SP-
Descrição: dc.descriptionDepartment of Internal Medicine Hospital das Clínicas São Paulo State University (UNESP)-
Idioma: dc.languageen-
Relação: dc.relationDiabetology and Metabolic Syndrome-
???dc.source???: dc.sourceScopus-
Palavras-chave: dc.subjectAntihyperglycemic drugs-
Palavras-chave: dc.subjectCorticosteroids-
Palavras-chave: dc.subjectCOVID-19-
Palavras-chave: dc.subjectDiabetes-
Palavras-chave: dc.subjectHyperglycemia-
Palavras-chave: dc.subjectInsulin-
Título: dc.titleHospital management of hyperglycemia in the context of COVID-19: evidence-based clinical considerations-
Tipo de arquivo: dc.typevídeo-
Aparece nas coleções:Repositório Institucional - Unesp

Não existem arquivos associados a este item.